Tirzepatide acetate 2023788-19-2 free base is a synthetic 39-amino-acid peptide engineered for laboratory research evaluating dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor activation. Identified by CAS number 2023788-19-2, this high-purity research compound is supplied exclusively for in vitro assaying, structural analysis, and preclinical receptor-binding studies.
Tirzepatide acetate 2023788-19-2 free base is a synthetic 39-amino-acid peptide engineered for laboratory research evaluating dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor activation. Identified by CAS number 2023788-19-2, this high-purity research compound is supplied exclusively for in vitro assaying, structural analysis, and preclinical receptor-binding studies.
In analytical chemistry and preclinical laboratory evaluation, tirzepatide acetate 2023788-19-2 free base represents a primary benchmark compound among novel incretin mimetics. The Chemical Abstracts Service (CAS) registry number 2023788-19-2 uniquely identifies the linear peptide sequence containing 39 amino acid residues, modified at the C-terminus with an amide and functionalized at Lys20 with a C20 fatty diacid moiety via a hydrophilic linker. This lipid conjugation allows researchers to examine protein binding kinetics, extended plasma half-life mechanisms, and receptor internalization dynamics in cell-free and cell-based models.
While often referenced interchangeably in early laboratory literature, the free base form and salt adducts (such as the acetate counterion complex) exhibit specific solubility profiles that dictate their preparation in non-clinical experiments. PX1 Research provides fully characterized tirzepatide research peptide preparations with precise salt content determination, ensuring quantitative reproducibility across spectrophotometric, chromatographic, and cell culture assays. Researchers interested in exploring related metabolic pathways can browse our comprehensive catalog of research peptides for complementary experimental reagents.
The primary biochemical significance of tirzepatide acetate 2023788-19-2 free base lies in its biased dual agonism at both the GIP and GLP-1 receptors. Preclinical binding studies suggest that the molecule exhibits equal potency to native GIP at the GIP receptor, while displaying approximately 5-fold weaker affinity for the GLP-1 receptor relative to native GLP-1. This uncoupled affinity profile alters intracellular signaling cascades, specifically cAMP accumulation and beta-arrestin recruitment, in transfectant cell lines.
In vitro data indicate that co-activation of these two distinct class B G-protein-coupled receptors (GPCRs) promotes synergistic stimulation of insulin secretion in isolated pancreatic islet models while suppressing glucagon gene expression under high-glucose conditions. Researchers studying signaling crosstalk often utilize our targeted dual GIP/GLP-1 agonists reference materials to map downstream phosphorylation pathways, including ERK1/2 and Akt activation. Additional details on receptor binding kinetics are documented within the PX1 research library.
When evaluating metabolic receptor pharmacology, researchers frequently contrast dual agonists with single-receptor ligands and emerging tri-agonists. Single-target GLP-1 analogues, such as semaglutide and liraglutide, focus exclusively on GLP-1 receptor recruitment, providing baseline parameters for insulinotropic potency and receptor desensitization. Conversely, dual GIP/GLP-1 agents like tirzepatide acetate 2023788-19-2 free base introduce GIP-mediated lipid turnover and adipocyte signaling dynamics into experimental models.
Advanced multi-target research compounds, such as the triple agonist retatrutide (which adds glucagon receptor activity to GIP and GLP-1 targets), represent the next frontier in comparative incretin assays. Comparing these distinct classes in parallel in vitro panels enables investigators to isolate the specific physiological contributions of each receptor pathway. Laboratories conducting high-throughput comparative assays can establish institutional purchasing agreements through our specialized wholesale lab accounts program.
Maintaining chemical fidelity in solid-phase peptide synthesis (SPPS) requires rigorous analytical validation before experimental deployment. For tirzepatide acetate 2023788-19-2 free base, PX1 Research subjects every production lot to strict quality control protocols in an ISO 17025 accredited laboratory environment. Primary purity evaluation is executed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), establishing chemical purity levels consistently exceeding 98.0%.
Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF analysis is performed concurrently to confirm the observed molecular weight against theoretical calculations (MW: 4813.45 g/mol for the neutral free base peptide sequence). Each lot includes a batch-specific Certificate of Analysis (COA) documenting precise RP-HPLC chromatograms, mass spectra, moisture content via Karl Fischer titration, and net peptide content. Detailed validation protocols are accessible via our dedicated GLP-1 receptor agonists technical documentation.
Bacterial endotoxins (lipopolysaccharides) introduce significant confounding variables into cellular assays, triggering non-specific inflammatory signaling pathways via Toll-like receptor 4 (TLR4). In cell culture models measuring cytokine release, adipogenesis, or gene transcription, elevated endotoxin levels ruin batch-to-batch consistency and skew data.
PX1 Research mandates strict endotoxin testing on all laboratory reagents using Chromogenic Reagent Kinetic Limulus Amebocyte Lysate (LAL) assays. Every batch of tirzepatide acetate 2023788-19-2 free base is certified to contain < 0.01 EU/μg, ensuring that in vitro observations reflect true peptide-receptor interactions rather than immune artifacts caused by bacterial contaminants.
Reconstitution parameters directly impact the physical stability and aggregation kinetics of synthetic lipidated peptides. Due to the hydrophobic C20 diacid chain present in tirzepatide acetate 2023788-19-2 free base, standard aqueous reconstitution must be approached with precise pH control to prevent self-assembly or precipitation.
For biological assays, initial solubilization in sterile, endotoxin-free phosphate-buffered saline (PBS, pH 7.4) or sterile bacteriostatic water is recommended. If high-concentration stock solutions (> 2 mg/mL) are required for analytical workflow, a minimal volume of dimethyl sulfoxide (DMSO, < 0.1% final assay concentration) or mild alkaline buffer adjustments may be employed. Detailed solvent compatibility matrix guidelines can be reviewed in our comprehensive peptide reconstitution guidelines.
Lyophilized tirzepatide acetate 2023788-19-2 free base powder exhibits high thermodynamic stability when maintained under controlled low-temperature environments. Upon receipt, unopened vials should be stored at -20°C or -80°C in a desiccated environment, shielded from light. Under these conditions, the solid matrix maintains analytical integrity for up to 24 months.
Following reconstitution, liquid stock solutions should be aliquoted into single-use low-binding polypropylene microcentrifuge tubes to prevent adsorption loss and avoid repeated freeze-thaw cycles. Reconstituted aliquots stored at 2°C to 8°C should be utilized within 7 to 14 days, whereas frozen aliquots (-80°C) remain stable for up to 90 days. Extreme thermal fluctuations and mechanical agitation must be avoided to prevent peptide aggregation.
Academic and pharmaceutical research groups utilize tirzepatide acetate 2023788-19-2 free base across a diverse array of non-clinical research domains:
1. Receptor Binding & Internalization: Evaluating differential ligand affinity, receptor trafficking, and beta-arrestin recruitment profiles in HEK293 or CHO cell lines stably expressing human GIPR and GLP-1R. 2. In Vitro Islet Secretion Assays: Quantifying glucose-stimulated insulin secretion (GSIS) dynamics in primary rodent pancreatic islets and INS-1 832/13 beta-cell lines. 3. Adipocyte Metabolic Pathways: Measuring lipolysis suppression and gene expression profiles (e.g., PPARγ, GLUT4) in 3T3-L1 adipocyte differentiation models. 4. Receptor Synergism Studies: Profiling downstream signaling cascades when combined with novel targeted research compounds from the PX1 research library.
Sourcing high-purity peptides for quantitative research requires absolute transparency and supply chain reliability. PX1 Research manufactures research compounds within state-of-the-art cGMP-compliant facilities located in the United States, enforcing stringent quality control measures from amino acid raw materials through final lyophilization.
To minimize transport degradation and maintain cold-chain continuity, orders are fulfilled directly from our strategic distribution centers located in California and Arizona. PX1 Research guarantees same-day shipping for all orders finalized Monday through Friday before 2:00 PM PST. Institutional labs requiring bulk quantities, custom synthesis options, or continuous lot matching can establish automated procurement protocols via our dedicated wholesale lab accounts department.
What is tirzepatide acetate 2023788-19-2 free base?
Tirzepatide acetate 2023788-19-2 free base is a synthetic 39-amino-acid research peptide categorized as a dual GIP and GLP-1 receptor agonist. Identified by CAS number 2023788-19-2, it is manufactured exclusively for in vitro laboratory research, analytical assaying, and preclinical receptor binding investigations.
What is the difference between tirzepatide free base and tirzepatide acetate salt?
The free base form refers to the unprotonated peptide sequence without counterions, whereas tirzepatide acetate includes acetic acid counterions associated with basic amino acid residues. Both forms represent the same core primary amino acid sequence, but salt adducts can influence initial solubility parameters during laboratory reconstitution.
How is the purity of tirzepatide acetate 2023788-19-2 free base verified?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) coupled with Mass Spectrometry (ESI-MS). PX1 Research guarantees an analytical purity threshold of ≥ 98.0%, verified via lot-specific Certificates of Analysis (COA).
What are the endotoxin limits for PX1 Research tirzepatide acetate?
Every lot of tirzepatide acetate 2023788-19-2 free base supplied by PX1 Research undergoes strict LAL testing to ensure endotoxin levels remain strictly under 0.01 EU/μg, protecting cell culture models from inflammatory artifacts.
How should tirzepatide acetate 2023788-19-2 free base be reconstituted for cell assays?
Reconstitution should be performed using sterile, endotoxin-free phosphate-buffered saline (PBS, pH 7.4) or sterile bacteriostatic water under a laminar flow hood. Gently swirl without vigorous vortexing to prevent peptide shearing or foaming.
What are the long-term storage requirements for lyophilized tirzepatide?
Lyophilized powder should be stored tightly sealed at -20°C or -80°C in a desiccated environment protected from light exposure, maintaining stability for up to 24 months.
How long do reconstituted liquid stock solutions remain stable?
Reconstituted stock solutions stored in single-use aliquots at 2°C to 8°C remain stable for up to 14 days. Frozen aliquots stored at -80°C retain functional activity for up to 90 days, provided repeated freeze-thaw cycles are avoided.
How does tirzepatide compare to semaglutide and retatrutide in laboratory studies?
In preclinical comparative models, semaglutide acts as a selective single GLP-1 receptor agonist, tirzepatide acts as a dual GIP/GLP-1 agonist, and retatrutide functions as a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously.
Where is PX1 Research tirzepatide acetate manufactured and shipped from?
PX1 Research peptides are synthesized in cGMP-compliant facilities within the USA. Orders are packed and dispatched same-day (Monday through Friday) from centralized fulfillment centers in California and Arizona.
Can academic laboratories establish wholesale accounts for bulk research orders?
Yes, high-volume academic laboratories, CROs, and institutional facilities can request dedicated pricing and lot-locking services through our wholesale lab accounts program.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.